IRD
Income statement / Annual
Last year (2025), Opus Genetics Inc.'s total revenue was $14.20 M,
an increase of 29.15% from the previous year.
In 2025, Opus Genetics Inc.'s net income was -$49.59 M.
See Opus Genetics Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$14.20 M |
$10.99 M |
$19.05 M |
$39.85 M |
$589.00 K |
$0.00 |
$0.00 |
| Cost of Revenue |
$53.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$14.14 M
|
$10.99 M
|
$19.05 M
|
$39.85 M
|
$589.00 K
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
| Research and Development Expenses |
$30.81 M
|
$26.85 M
|
$17.65 M
|
$14.36 M
|
$15.17 M
|
$6.65 M
|
$2.37 M
|
| General & Administrative Expenses |
$21.98 M
|
$18.22 M
|
$11.96 M
|
$7.27 M
|
$8.12 M
|
$2.82 M
|
$1.82 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$21.98 M
|
$18.22 M
|
$11.96 M
|
$7.27 M
|
$8.12 M
|
$2.82 M
|
$1.82 M
|
| Other Expenses |
$0.00
|
$28.00 M
|
$0.00
|
$0.00
|
$0.00
|
$10.50 M
|
$0.00
|
| Operating Expenses |
$52.80 M
|
$73.07 M
|
$29.61 M
|
$21.62 M
|
$23.29 M
|
$19.97 M
|
$4.19 M
|
| Cost And Expenses |
$52.80 M
|
$73.07 M
|
$29.61 M
|
$21.62 M
|
$23.29 M
|
$19.97 M
|
$4.19 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$1.47 M
|
$0.00
|
$1.33 M
|
$9.00 K
|
$2.00 K
|
$6.85 M
|
$1.41 M
|
| Depreciation & Amortization |
$53.00 K
|
$10.00 K
|
$6.00 K
|
$4.00 K
|
$4.00 K
|
$8.00 K
|
$3.00 K
|
| EBITDA |
-$38.60 M |
-$57.52 M |
-$9.97 M |
$18.22 M |
-$56.69 M |
-$17.77 M |
-$4.76 M |
| EBITDA Ratio |
-2.72
|
-5.23
|
-0.52
|
0.46
|
-96.24
|
0
|
0
|
| Operating Income Ratio |
-2.72
|
-5.65
|
-0.55
|
0.46
|
-38.55
|
0
|
0
|
| Total Other Income/Expenses Net |
-$10.99 M
|
$4.54 M
|
$589.00 K
|
-$23.00 K
|
-$33.99 M
|
-$4.65 M
|
-$1.98 M
|
| Income Before Tax |
-$49.59 M
|
-$57.53 M
|
-$9.97 M
|
$18.20 M
|
-$56.69 M
|
-$24.62 M
|
-$6.17 M
|
| Income Before Tax Ratio |
-3.49
|
-5.23
|
-0.52
|
0.46
|
-96.25
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$12.00 K
|
$315.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$49.59 M
|
-$57.53 M
|
-$9.99 M
|
$17.89 M
|
-$56.69 M
|
-$24.62 M
|
-$6.17 M
|
| Net Income Ratio |
-3.49
|
-5.23
|
-0.52
|
0.45
|
-96.25
|
0
|
0
|
| EPS |
-0.8 |
-2.15 |
-0.46 |
0.9 |
-3.82 |
-5.28 |
-0.87 |
| EPS Diluted |
-0.8 |
-2.15 |
-0.46 |
0.87 |
-3.82 |
-5.28 |
-0.87 |
| Weighted Average Shares Out |
$622.22 M
|
$26.72 M
|
$21.59 M
|
$19.93 M
|
$14.85 M
|
$4.66 M
|
$7.09 M
|
| Weighted Average Shares Out Diluted |
$622.22 M
|
$26.72 M
|
$21.59 M
|
$20.60 M
|
$14.85 M
|
$4.66 M
|
$7.09 M
|
| Link |
|
|
|
|
|
|
|
